Androgen deprivation therapy plus salvage radiotherapy after prostatectomy - Authors' reply

Lancet Oncol. 2020 Jan;21(1):e13. doi: 10.1016/S1470-2045(19)30813-7.

Authors

Christian Carrie¹, Sylvie Chabaud²

Affiliations

¹ Radiotherapy Department, Léon Bérard Center, Lyon, France; CNRS UMR 5220, INSERM U1044, INSA, University of Lyon, Lyon, France. Electronic address: christian.carrie@lyon.unicancer.fr.
² Biostatistics Unit, Clinical Research and Innovation Department, Léon Bérard Cancer Centre, Lyon, France.

PMID: 31908299
DOI: 10.1016/S1470-2045(19)30813-7

No abstract available

Publication types

Letter
Comment

MeSH terms

Androgen Antagonists
Follow-Up Studies
Humans
Male
Prostate-Specific Antigen
Prostatectomy
Prostatic Neoplasms / surgery*
Salvage Therapy*

Substances

Androgen Antagonists
Prostate-Specific Antigen